Characterisation of multipotent stem cells from human peripheral blood using an improved protocol.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Tissue Engineering

Background:

• Mesenchymal stem cells (MSCs) are crucial for bone repair but sourcing them is challenging.
• Peripheral blood (PB) offers a minimally invasive source for MSCs.
• This study investigates the potential of PB-MSCs for bone regeneration.

Purpose of the Study:

• To evaluate the multipotency of human peripheral blood-derived MSCs (PB-MSCs).
• To assess the efficacy of PB-MSCs transplantation in ectopic bone regeneration in vivo.
• To establish an effective method for isolating and culturing PB-MSCs.

Main Methods:

• Human venous blood was processed to isolate red blood cells.
• Cells were cultured under normoxia and hypoxia, with plastic-adherent cells selected.
• Multi-differentiation assays and in vivo ectopic bone formation assays were performed.

Main Results:

• Hypoxia-cultured cells exhibited robust multi-lineage differentiation potential and expressed key markers (Nanog, Lgr5, MSC antigens).
• Histological examination confirmed ectopic bone regeneration following human PB-MSC transplantation.
• A 60% success rate was achieved in obtaining purified MSCs rapidly.

Conclusions:

• An effective method for harvesting highly purified MSCs with multipotency from human peripheral blood was developed.
• Lgr5 may serve as a biomarker for identifying a subpopulation of PB-MSCs.
• PB-MSCs represent a promising alternative cell source for cell therapy and bone repair applications.